What is Zacks Research’s Forecast for CENTA FY2025 Earnings?

Central Garden & Pet (NASDAQ:CENTAFree Report) – Equities research analysts at Zacks Research boosted their FY2025 earnings estimates for shares of Central Garden & Pet in a research report issued on Wednesday, February 19th. Zacks Research analyst S. Singh now anticipates that the company will post earnings of $2.35 per share for the year, up from their previous forecast of $2.22. The consensus estimate for Central Garden & Pet’s current full-year earnings is $2.38 per share. Zacks Research also issued estimates for Central Garden & Pet’s Q4 2025 earnings at ($0.15) EPS, Q1 2026 earnings at $0.16 EPS, Q4 2026 earnings at ($0.13) EPS, FY2026 earnings at $2.40 EPS and Q1 2027 earnings at $0.18 EPS.

Central Garden & Pet (NASDAQ:CENTAGet Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.24. Central Garden & Pet had a return on equity of 10.08% and a net margin of 3.77%.

A number of other research firms have also recently weighed in on CENTA. JPMorgan Chase & Co. lowered their target price on shares of Central Garden & Pet from $32.00 to $31.00 and set a “neutral” rating on the stock in a research note on Thursday, January 16th. StockNews.com upgraded Central Garden & Pet from a “hold” rating to a “buy” rating in a research note on Thursday, February 6th. Finally, Argus cut Central Garden & Pet from a “buy” rating to a “hold” rating in a report on Tuesday, January 7th. Two investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Central Garden & Pet presently has a consensus rating of “Moderate Buy” and a consensus target price of $41.00.

Check Out Our Latest Stock Analysis on Central Garden & Pet

Central Garden & Pet Price Performance

Shares of NASDAQ:CENTA opened at $31.32 on Monday. The business’s 50 day moving average is $32.12 and its 200-day moving average is $32.18. The company has a current ratio of 3.47, a quick ratio of 1.97 and a debt-to-equity ratio of 0.78. The firm has a market capitalization of $2.05 billion, a PE ratio of 17.21 and a beta of 0.76. Central Garden & Pet has a 1-year low of $27.70 and a 1-year high of $41.03.

Insiders Place Their Bets

In other Central Garden & Pet news, insider John D. Walker III sold 10,000 shares of the business’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $32.86, for a total value of $328,600.00. Following the completion of the transaction, the insider now directly owns 67,111 shares of the company’s stock, valued at approximately $2,205,267.46. The trade was a 12.97 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 20.28% of the company’s stock.

Institutional Investors Weigh In On Central Garden & Pet

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. FMR LLC lifted its position in shares of Central Garden & Pet by 33.8% in the third quarter. FMR LLC now owns 76,388 shares of the company’s stock worth $2,399,000 after purchasing an additional 19,306 shares in the last quarter. Barclays PLC lifted its position in Central Garden & Pet by 161.7% during the 3rd quarter. Barclays PLC now owns 122,530 shares of the company’s stock worth $3,849,000 after buying an additional 75,718 shares in the last quarter. Congress Asset Management Co. boosted its stake in shares of Central Garden & Pet by 9.5% during the 4th quarter. Congress Asset Management Co. now owns 195,847 shares of the company’s stock worth $6,473,000 after buying an additional 17,033 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Central Garden & Pet by 5.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 773,023 shares of the company’s stock valued at $24,273,000 after acquiring an additional 41,241 shares during the last quarter. Finally, Empowered Funds LLC raised its holdings in Central Garden & Pet by 5.1% during the fourth quarter. Empowered Funds LLC now owns 255,113 shares of the company’s stock worth $8,431,000 after acquiring an additional 12,413 shares in the last quarter. 50.82% of the stock is currently owned by institutional investors and hedge funds.

About Central Garden & Pet

(Get Free Report)

Central Garden & Pet Co engages in the production and distribution of branded and private label products for the lawn, garden, and pet supplies markets. It operates through the Pet and Garden segments. The Pet segment focuses on dog and cat supplies such as dog treats and chews, toys, pet beds and containment, grooming products, waste management and training pads, supplies for aquatics, small animals, reptiles and pet birds including toys, cages and habitats, bedding, food and supplements, products for equine and livestock, animal and household health and insect control products, live fish and small animals as well as outdoor cushions.

Recommended Stories

Earnings History and Estimates for Central Garden & Pet (NASDAQ:CENTA)

Receive News & Ratings for Central Garden & Pet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Central Garden & Pet and related companies with MarketBeat.com's FREE daily email newsletter.